Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes

2013 ESH/ESC Guidelines for the management of arterial hypertension

Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,638 · see citing works

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315 · see citing works

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Lang, R., Badano, L., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F., Foster, E., Goldstein, S., Kuznetsova, T., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.10.003 · Cited by 10,093 · see citing works

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Lang, R. M., Badano, L. P., Mor‐Avi, V., Afilalo, J., Armstrong, A. D. C., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev014 · Cited by 8,449 · see citing works

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · see citing works

[49] Determination of carbonyl content in oxidatively modified proteins

Levine, R. L., Garland, D. L., Oliver, C. N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B. W., Shaltiel, S., & Stadtman, E. R. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)86141-h · Cited by 5,895 · see citing works

The Physiology of Glucagon-like Peptide 1

Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · see citing works

Diabetes, oxidative stress, and antioxidants: A review

Maritim, A. C., Sanders, R. A., & Watkins, J. B. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10058 · Cited by 3,128 · see citing works

The biology of incretin hormones

Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210 · see citing works

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,958 · see citing works

Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors

Nielsen, F., Mikkelsen, B. B., Nielsen, J. B., Andersen, H. R., & Grandjean, P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.7.1209 · Cited by 1,017 · see citing works

Biochemical detection of left-ventricular systolic dysfunction

McDonagh, T., Robb, S., Murdoch, D. R., Morton, J. J., Ford, I., Morrison, C., Tunstall‐Pedoe, H., McMurray, J. J. V., & Dargie, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03034-1 · Cited by 958 · see citing works

GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody

Pyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876 · cited 1× · see citing works

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)

Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., Huikuri, H., et al. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609 · see citing works

Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy

Nikolaidis, L., Elahi, D., Hentosz, T., Doverspike, A., Huerbin, R., Zourelias, L., Stolarski, C. J., Shen, Y.-T., & Shannon, R. (2004) · Circulation · doi:10.1161/01.cir.0000139339.85840.dd · Cited by 546 · see citing works

Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy

Yamamoto, K., Burnett, J. C. J., Jougasaki, M., Nishimura, R. A., Bailey, K. R., Saito, Y., Nakao, K., & Redfield, M. M. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.988 · Cited by 518 · see citing works

Increased Central Artery Stiffness in Impaired Glucose Metabolism and Type 2 Diabetes

Schram, M. T., Henry, R. M. A., van Dijk, R. A. J. M., Kostense, P. J., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., Westerhof, N., & Stehouwer, C. D. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000111829.46090.92 · Cited by 439 · see citing works

Cytokine-Induced Modulation of Cardiac Function

Prabhu, S. D. (2004) · Circulation Research · doi:10.1161/01.res.0000150734.79804.92 · Cited by 375 · see citing works

Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.

Kinnunen, P., Vuolteenaho, O. J., & Ruskoaho, H. J. (1993) · Endocrinology · doi:10.1210/endo.132.5.8477647 · Cited by 332 · see citing works

Left Ventricular Form and Function Revisited: Applied Translational Science to Cardiovascular Ultrasound Imaging

Sengupta, P. P., Krishnamoorthy, V. K., Korinek, J. K., Narula, J., Vannan, M. A., Lester, S. J., Tajik, J. A., Seward, J. B., Khandheria, B. K., & Bëlohlávek, M. (2007) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2006.10.013 · Cited by 323 · see citing works

Findings from Left Ventricular Strain and Strain Rate Imaging in Asymptomatic Patients With Type 2 Diabetes Mellitus

Ng, A. C. T., Delgado, V., Bertini, M., van der Meer, R. W., Rijzewijk, L. J., Shanks, M., Nucifora, G., Smit, J. W. A., Diamant, M., Romijn, J. A., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.06.063 · Cited by 296 · see citing works

Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis.

Robinson, L. E., Holt, T. A., Rees, K., Randeva, H. S., & O'Hare, J. P. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-001986 · Cited by 296 · see citing works

Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes

Odegaard, A. O., Jacobs, D. R., Sanchez, O. A., Goff, D. C., Reiner, A. P., & Gross, M. D. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0369-6 · Cited by 286 · see citing works

A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity

Noyan-Ashraf, M. H., Shikatani, E. A., Schuiki, I., Mukovozov, I., Wu, J., Li, R.-K., Volchuk, A., Robinson, L. A., Billia, F., Drucker, D. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.091215 · Cited by 259 · see citing works

Additional Prognostic Value of Coronary Flow Reserve in Diabetic and Nondiabetic Patients With Negative Dipyridamole Stress Echocardiography by Wall Motion Criteria

Cortigiani, L., Rigo, F., Gherardi, S., Sicari, R., Galderisi, M., Bovenzi, F., & Picano, E. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.027 · Cited by 182 · see citing works

Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus

Holland, D. J., Marwick, T. H., Haluska, B. A., Leano, R., Hordern, M., Hare, J., Fang, Z. Y., Prins, J. B., & Stanton, T. (2015) · Heart · doi:10.1136/heartjnl-2014-307391 · Cited by 181 · see citing works

Cardiac Metabolism as a Target for the Treatment of Heart Failure

Taegtmeyer, H. (2004) · Circulation · doi:10.1161/01.cir.0000139340.88769.d5 · Cited by 178 · see citing works

Liraglutide Promotes Natriuresis but Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 Diabetes

Lovshin, J. A., Barnie, A., DeAlmeida, A., Logan, A., Zinman, B., & Drucker, D. J. (2015) · Diabetes Care · doi:10.2337/dc14-1958 · Cited by 168 · see citing works

Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis

Ikonomidis, I., Tzortzis, S., Andreadou, I., PARASKEVAIDIS, I. A., Katseli, C., Katsimbri, P., Pavlidis, G., Parissis, J., Kremastinos, D. T., ANASTASIOU‐NANA, M. I., et al. (2014) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.001193 · Cited by 160 · see citing works

GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons

Griffioen, K. J. S., Wan, R., Okun, E., Wang, X., Lovett-Barr, M. R., Li, Y., Mughal, M. R., Mendelowitz, D., & Mattson, M. P. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq271 · Cited by 110 · see citing works

The Population Burden of Heart Failure Attributable to Modifiable Risk Factors

Avery, C. L., Loehr, L. R., Baggett, C. D., Chang, P. P., Kucharska‐Newton, A., Matsushita, K., Rosamond, W. D., & HEISS, G. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.022 · Cited by 105 · see citing works

Determinants of vascular function in patients with type 2 diabetes

Naka, K. Κ., Papathanassiou, K., Bechlioulis, A., Kazakos, N., Pappas, K. D., Tigas, S. K., Makriyiannis, D., Tsatsoulis, A. A., & Michalis, L. K. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-127 · Cited by 100 · see citing works

Incremental Value of Pulse Wave Velocity in the Determination of Coronary Microcirculatory Dysfunction in Never-treated Patients With Essential Hypertension

Ikonomidis, I., Lekakis, J. P., Papadopoulos, C. H., Triantafyllidi, H., PARASKEVAIDIS, I. A., Georgoula, G., Tzortzis, S., Revela, I., & Kremastinos, D. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.172 · Cited by 96 · see citing works

Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus

Mochizuki, Y., Tanaka, H., Matsumoto, K., Sano, H., Toki, H., Shimoura, H., Ooka, J., Sawa, T., Motoji, Y., Ryo, K., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0201-8 · Cited by 92 · see citing works

Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models

Villanueva-Peñacarrillo, M., Puente, J., Redondo, A., Clemente, F., & Valverde, I. (2001) · Endocrine · doi:10.1385/endo:15:2:241 · Cited by 91 · see citing works

The Potential Beneficial Role of Glucagon-like Peptide-1 in Endothelial Dysfunction and Heart Failure Associated with Insulin Resistance

Nyström, T. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1082326 · Cited by 76 · see citing works

Similarities in Coronary Function and Myocardial Deformation Between Psoriasis and Coronary Artery Disease: The Role of Oxidative Stress and Inflammation

Ikonomidis, I., Makavos, G., Papadavid, E., Varoudi, M., Andreadou, I., Gravanis, K., Theodoropoulos, K., Pavlidis, G., Triantafyllidi, H., Parissis, J., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.11.002 · Cited by 76 · see citing works

Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis

Song, X., Jia, H., Jiang, Y., Wang, L., Zhang, Y., Mu, Y., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep10202 · Cited by 76 · see citing works

Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function

Forst, T., Michelson, G., Ratter, F., Weber, M. M., Anders, S., Mitry, M., Wilhelm, B., & Pfützner, A. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03589.x · Cited by 75 · see citing works

Exenatide improves diastolic function and attenuates arterial stiffness but does not alter exercise capacity in individuals with type 2 diabetes

Scalzo, R. L., Moreau, K. L., Ozemek, C., Herlache, L., McMillin, S. L., Gilligan, S., Huebschmann, A. G., Bauer, T. A., Dorosz, J. L., Reusch, J. E. B., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.003 · Cited by 73 · see citing works

Exenatide Improves Glucose Homeostasis and Prolongs Survival in a Murine Model of Dilated Cardiomyopathy

Vyas, A. K., Yang, K., Woo, D., Tzekov, A., Kovács, A. D., Jay, P. Y., & Hruz, P. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017178 · Cited by 57 · see citing works

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study

Kumarathurai, P., Anholm, C., Nielsen, O. W., Kristiansen, O. P., Mølvig, J., Madsbad, S., Haugaard, S. B., & Sajadieh, A. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0425-2 · Cited by 54 · see citing works

A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2)

Nomoto, H., Miyoshi, H., Furumoto, T., Oba, K., Tsutsui, H., Miyoshi, A., Kondo, T., Tsuchida, K., Atsumi, T., Manda, N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135854 · Cited by 52 · see citing works

Pulsatile Hemodynamics and Clinical Outcomes in Acute Heart Failure

Sung, S., Yu, W. C., Cheng, H., Chuang, S., Wang, K.-L., Huang, C.-M., & Chen, C. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.26 · Cited by 43 · see citing works

Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case–control study

Sagara, M., Suzuki, K., Aoki, C., Tanaka, S., Taguchi, I., Inoue, T., & Aso, Y. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0396-3 · Cited by 40 · see citing works

Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers

Gurkan, E., Tarkun, I., Sahin, T., Cetinarslan, B., & Canturk, Z. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.046 · Cited by 38 · see citing works

Imaging Heart Failure: Current and Future Applications

Paterson, D. I., Mielniczuk, L. M., O’Meara, E., So, A., & White, J. A. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.01.006 · Cited by 36 · see citing works

Effect of Aliskiren on Circulating Endothelial Progenitor Cells and Vascular Function in Patients With Type 2 Diabetes and Essential Hypertension

Raptis, A. E., Markakis, K. P., Mazioti, M. C., Ikonomidis, I., Maratou, E., Vlahakos, D., Kotsifaki, E., Voumvourakis, A., Tsirogianni, A., Lambadiari, V., et al. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu119 · Cited by 33 · see citing works

Effects of Darbepoetin Alfa on Plasma Mediators of Oxidative and Nitrosative Stress in Anemic Patients With Chronic Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy

Parissis, J., Kourea, K., Andreadou, I., Ikonomidis, I., Markantonis, S. L., Ioannidis, K., PARASKEVAIDIS, I. A., Iliodromitis, E. K., Filippatos, G. S., & Kremastinos, D. T. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.12.041 · Cited by 31 · see citing works

Liraglutide for the Treatment of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Placebo-Controlled Trials

Du, Q., Wang, Y.-J., Yang, S., Zhao, Y.-Y., & Han, P. (2014) · Advances in Therapy · doi:10.1007/s12325-014-0164-2 · Cited by 26 · see citing works

Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study

Tomiyama, H., Miwa, T., Kan, K., Matsuhisa, M., Kamiya, H., Nanasato, M., Kitano, T., Sano, H., Ohno, J., Iida, M., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0472-8 · Cited by 17 · see citing works

The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., & van Raalte, D. H. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.12.011 · Cited by 16 · see citing works

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Tan, Y., Zhang, Z., Zheng, C., Wintergerst, K. A., Keller, B. B., & Cai, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0339-2 · Cited by 846 · see citing works

The Role of Ventricular–Arterial Coupling in Cardiac Disease and Heart Failure: Assessment, Clinical Implications and Therapeutic Interventions. A Consensus Document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association

Ikonomidis, I., Aboyans, V., Blacher, J., Brodmann, M., Brutsaert, D. L., Chirinos, J. A., Carlo, M. D., Delgado, V., Lancellotti, P., Lekakis, J. P., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1436 · Cited by 396 · see citing works

Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging

Ng, A. C. T., Delgado, V., Borlaug, B. A., & Bax, J. J. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00465-5 · Cited by 339 · see citing works

Concept of Extremes in Vascular Aging

Laurent, S., Boutouyrie, P., Cunha, P., Lacolley, P. J., & Nilsson, P. M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12655 · Cited by 226 · see citing works

The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction

Withaar, C., Meems, L. M. G., Markousis-Mavrogenis, G., Boogerd, C. J., Silljé, H. H. W., Schouten, E. M., Dokter, M. M., Voors, A. A., Westenbrink, B. D., Lam, C. S. P., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa256 · Cited by 223 · see citing works

Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment

Ikonomidis, I., Pavlidis, G., Thymis, J., Birba, D., Kalogeris, A., Kousathana, F., Kountouri, A., Balampanis, K., Parissis, J., Andreadou, I., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015716 · Cited by 199 · see citing works

<scp>Glucagon‐like peptide‐1 receptor agonists</scp> improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials

Bray, J. J. H., Foster‐Davies, H., Salem, A., Hoole, A. L., Obaid, D. R., Halcox, J. P. J., & Stephens, J. W. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14399 · Cited by 194 · see citing works

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis

Fei, Y., Tsoi, M. F., & Cheung, B. M. Y. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0916-z · Cited by 158 · see citing works

Centrally Acting Agents for Obesity: Past, Present, and Future

Coulter, A. A., Rebello, C. J., & Greenway, F. L. (2018) · Drugs · doi:10.1007/s40265-018-0946-y · Cited by 151 · see citing works

The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome

Bednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148 · see citing works

Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis

Batzias, K., Antonopoulos, A. S., Oikonomou, E. K., Siasos, G., Bletsa, E., Stampouloglou, P. K., Mistakidi, C. V., Noutsou, M., Katsiki, N., Karopoulos, P., et al. (2018) · Journal of Diabetes Research · doi:10.1155/2018/1232583 · Cited by 142 · see citing works

Vascular ageing: moving from bench towards bedside

Climie, R. E., Alastruey, J., Mayer, C. C., Schwarz, A., Laučytė-Cibulskienė, A., Voicehovska, J., Bianchini, E., Bruno, R. M., Charlton, P. H., Grillo, A., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad028 · Cited by 139 · see citing works

Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: Randomized placebo-controlled trial

Bizino, M. B., Jazet, I. M., Westenberg, J. J. M., van Eyk, H. J., Paiman, E. H. M., Smit, J. W. A., & Lamb, H. J. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0857-6 · Cited by 137 · see citing works

Diabetic cardiomyopathy: Clinical phenotype and practice

Zhao, X., Liu, S., Wang, X., Chen, Y., Pang, P., Yang, Q., Lin, J., Deng, S., Shen-tao, W., Fan, G., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1032268 · Cited by 122 · see citing works

Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart

Markus, M. R. P., Rospleszcz, S., Ittermann, T., Baumeister, S. E., Schipf, S., Siewert‐Markus, U., Lorbeer, R., Storz, C., Ptushkina, V., Peters, A., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0948-4 · Cited by 120 · see citing works

Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress

Luna-Marco, C., Iannantuoni, F., Hermo-Argibay, A., Devos, D., Salazar, J. D., Víctor, V. M., & Rovira-Llopis, S. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.015 · Cited by 114 · see citing works

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

Bain, S. C., Mosenzon, O., Arechavaleta, R., Bogdański, P., Çömlekçi, A., Consoli, A., Deerochanawong, C., Dungan, K. M., Faingold, M. C., Farkouh, M. E., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13553 · Cited by 100 · see citing works

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus

Lunder, M., Janić, M., Japelj, M., Juretič, A., Janež, A., & Šabović, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0797-6 · Cited by 97 · see citing works

Metabolic and vascular insulin resistance: partners in the pathogenesis of cardiovascular disease in diabetes

Horton, W. B., Love, K. M., Gregory, J. M., Liu, Z., & Barrett, E. J. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00826.2024 · Cited by 83 · see citing works

Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy

Dhalla, N. S., Shah, A. K., & Tappia, P. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072413 · Cited by 78 · see citing works

Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study

for the Relationship between Cardiovascular disease and Brachial-ankle Pulse Wave Velocity (baPWV) in Patients with Type 2 Diabetes (REBOUND) Study Group, Kim, J. M., Kim, S. S., Kim, I. J., Kim, J. H., Kim, B. H., Kim, M.-K., Lee, S. H., Lee, C. W., Kim, M. C., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01120-6 · Cited by 78 · see citing works

The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF

Withaar, C., Meems, L. M. G., Nollet, E. E., Schouten, E. M., Schroeder, M. A., Knudsen, L. B., Niss, K., Madsen, C. T., Hoegl, A., Mazzoni, G., et al. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.012 · Cited by 74 · see citing works

Vasodilatory Actions of Glucagon-Like Peptide 1 Are Preserved in Skeletal and Cardiac Muscle Microvasculature but Not in Conduit Artery in Obese Humans With Vascular Insulin Resistance

Wang, N., Tan, A. W. K., Jahn, L. A., Hartline, L. M., Patrie, J. T., Lin, S., Barrett, E. J., Aylor, K. W., & Liu, Z. (2019) · Diabetes Care · doi:10.2337/dc19-1465 · Cited by 73 · see citing works

Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence

Natali, A., Nesti, L., Tricò, D., & Ferrannini, E. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01385-5 · Cited by 70 · see citing works

Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial

Tuttolomondo, A., Cirrincione, A., Casuccio, A., Cuore, A. D., Daidone, M., Chiara, T. D., Raimondo, D. D., Corte, V. D., Maida, C. D., Simonetta, I., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01183-5 · Cited by 70 · see citing works

Vascular Aging and Disease of the Large Vessels: Role of Inflammation

Maloberti, A., Vallerio, P., Triglione, N., Occhi, L., Panzeri, F., Bassi, I., Pansera, F., Piccinelli, E., Peretti, A., Garatti, L., et al. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00318-4 · Cited by 68 · see citing works

Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis

Zhang, D.-P., Xu, L., Wang, L., Wang, H.-J., & Jiang, F. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-0987-x · Cited by 64 · see citing works

Metformin monotherapy for adults with type 2 diabetes mellitus

Gnesin, F., Thuesen, A. C. B., Kähler, L. K. A., Madsbad, S., & Hemmingsen, B. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012906.pub2 · Cited by 62 · see citing works

Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression

Rivera, F. B., Lumbang, G. N. O., Gaid, D. R. M., Cruz, L. L. A., Magalong, J. V., Bantayan, N. R. B., Lara-Breitinger, K. M., Gulati, M., & Bakris, G. L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15529 · Cited by 59 · see citing works

The protective effects of lixisenatide against inflammatory response in human rheumatoid arthritis fibroblast-like synoviocytes

Du, X., Zhang, H., Zhang, W., Wang, Q., Wang, W., Ge, G., Bai, J., Guo, X., Zhang, Y., Jiang, X., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105732 · Cited by 55 · see citing works

Diabetes pathogenesis and management: the endothelium comes of age

Love, K. M., Barrett, E. J., Malin, S. K., Reusch, J. E. B., Regensteiner, J. G., & Liu, Z. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab024 · Cited by 55 · see citing works

How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?

Lee, M. M. Y., Petrie, M. C., McMurray, J. J. V., & Sattar, N. A. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.311904 · Cited by 56 · see citing works

Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet

Sukumaran, V., Tsuchimochi, H., Sonobe, T., Waddingham, M. T., Shirai, M., & Pearson, J. T. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01000-z · Cited by 52 · see citing works

Gut microbiota regulates cardiac ischemic tolerance and aortic stiffness in obesity

Battson, M. L., Lee, D. M., Puma, L. C. L., Ecton, K. E., Thomas, K. N., Febvre, H. P., Chicco, A. J., Weir, T. L., & Gentile, C. L. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00346.2019 · Cited by 51 · see citing works

Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the Atherosclerosis Risk in Communities Study

Poon, A. K., Meyer, M. L., Tanaka, H., Selvin, E., Pankow, J. S., Zeng, D., Loehr, L. R., Knowles, J. W., Rosamond, W. D., & HEISS, G. M. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-0986-y · Cited by 46 · see citing works

Vascular aging and cardiovascular disease: pathophysiology and measurement in the coronary arteries

Cheng, D. C., Climie, R. E., Shu, M. W. S., Grieve, S. M., Kozor, R., & Figtree, G. A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1206156 · Cited by 45 · see citing works

Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes

Lambadiari, V., Thymis, J., Kouretas, D., Skaperda, Z., Tekos, F., Kousathana, F., Kountouri, A., Balampanis, K., Parissis, J., Andreadou, I., et al. (2021) · Antioxidants · doi:10.3390/antiox10091379 · Cited by 42 · see citing works

Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double‐Blind, Randomized, Placebo‐Controlled Trial

Paiman, E. H. M., van Eyk, H. J., van Aalst, M., Bizino, M. B., van der Geest, R. J., Westenberg, J. J. M., Geelhoed-Duijvestijn, P. H. L. M., Kharagjitsingh, A. V., Rensen, P. C. N., Smit, J. W. A., et al. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27009 · Cited by 42 · see citing works

Arterial Stiffness and Heart Failure With Preserved Ejection Fraction

Kim, H., & Jo, S. (2024) · Journal of Korean Medical Science · doi:10.3346/jkms.2024.39.e195 · Cited by 43 · see citing works

<scp>GLP</scp>‐1 and insulin regulation of skeletal and cardiac muscle microvascular perfusion in type 2 diabetes

Love, K. M., Liu, J., Regensteiner, J. G., Reusch, J. E. B., & Liu, Z. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13045 · Cited by 40 · see citing works

The protective effects of liraglutide on AD-like neurodegeneration induced by oxidative stress in human neuroblastoma SH-SY5Y cells

Zheng, C., Zhou, M., Sun, J., Xiong, H., Peng, P., Gu, Z., & Deng, Y. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.06.001 · Cited by 40 · see citing works

Comparative effects of weight loss and incretin‐based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial

Mashayekhi, M., Beckman, J. A., Nian, H., Garner, E. M., Mayfield, D., Wright, P., Howard, S. E., Perkins, B., Olson, D., Snyder, W. E., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14903 · Cited by 43 · see citing works

GLP-1 Receptor Agonists and Myocardial Perfusion: Bridging Mechanisms to Clinical Outcomes

Karakasis, P., Patoulias, D., Theofilis, P., Pamporis, K., Sagris, Μ., Vlachakis, P. K., Koufakis, T., Antoniadis, A. P., & Fragakis, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073050 · Cited by 36 · see citing works

Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus

Moreno, B. V. D., de Faria, A. P., Ritter, A. M. V., Yugar, L. B. T., Ferreira‐Melo, S. E., de Amorim, R. F. B., Modolo, R., Fattori, A., Yugar‐Toledo, J. C., Coca, A., et al. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13293 · Cited by 34 · see citing works

Pharmacological modulation of vascular ageing: A review from VascAgeNet

Roth, L., Doğan, S., Tuna, B. G., Arányi, T., Benı́tez, S., Borrell-Pagés, M., Bozaykut, P., Meyer, G. R. Y. D., Duca, L., Durmuş, N., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102122 · Cited by 36 · see citing works

Liraglutide Promotes the Osteogenic Differentiation in MC3T3-E1 Cells via Regulating the Expression of Smad2/3 Through PI3K/Akt and Wnt/β-Catenin Pathways

Gao, L., Li, S., & Li, Y. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4397 · Cited by 33 · see citing works

Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow–Up Study

Lambadiari, V., Pavlidis, G., Kousathana, F., Maratou, E., Georgiou, D., Andreadou, I., Kountouri, A., Varoudi, M., Balampanis, K., Parissis, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070983 · Cited by 33 · see citing works

Circulating and Urinary Concentrations of Malondialdehyde in Aging Humans in Health and Disease: Review and Discussion

Tsikas, D., Tsikas, S. A., Mikuteit, M., & Ückert, S. (2023) · Biomedicines · doi:10.3390/biomedicines11102744 · Cited by 32 · see citing works

The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study

Bechlioulis, A., Markozannes, G., Chionidi, I., Liberopoulos, E. N., Naka, K. Κ., Ntzani, E., Liatis, S., Rizzo, M., & Rizos, E. C. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108436 · Cited by 31 · see citing works

Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targets

Ye, W., Han, K., Xie, M., Li, S., Chen, G., Wang, Y., & Li, T. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003075 · Cited by 30 · see citing works

Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials

Tanaka, A., & Node, K. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0731-y · Cited by 30 · see citing works

Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice

Tentolouris, A., Eleftheriadou, I., Tzeravini, E., Tsilingiris, D., Paschou, S. Α., Siasos, G., & Tentolouris, N. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190119154152 · Cited by 30 · see citing works

Interventions targeted at oxidatively generated modifications of nucleic acids focused on urine and plasma markers

Larsen, E. L., Weimann, A., & Poulsen, H. E. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.030 · Cited by 30 · see citing works

Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial

Vernstrøm, L., Gullaksen, S., Sørensen, S. S., Funck, K. L., Laugesen, E., & Poulsen, P. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15464 · Cited by 30 · see citing works

The Effect of Additional Treatment with Empagliflozin or Semaglutide on Endothelial Function and Arterial Stiffness in Subjects with Type 1 Diabetes Mellitus—ENDIS Study

Navodnik, M. P., Janež, A., & Žuran, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071945 · Cited by 28 · see citing works

Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease

Wang, T., Ding, J., Cheng, X., Yang, Q., & Hu, P. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1396656 · Cited by 29 · see citing works

The effect of GLP-1 receptor agonists on N-terminal pro-brain natriuretic peptide. A scoping review and metanalysis

Avogaro, A., Azzolina, D., Gregori, D., de Kreutzenberg, S., Fadini, G. P., & Mannucci, E. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.03.032 · Cited by 27 · see citing works

Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension

King, N. E., & Brittain, E. L. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12028 · Cited by 28 · see citing works

Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators

García‐Vega, D., González‐Juanatey, J. R., & Eiras-Penas, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147886 · Cited by 25 · see citing works

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

Sivalingam, S., Larsen, E. L., van Raalte, D. V., Muskiet, M. H., Smits, M., Tonneijck, L., Joles, J., von Scholten, B. J., Zobel, E., Persson, F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90191-w · Cited by 16 · see citing works

Glucagon‐like peptide‐1 receptor agonist treatment of high carbohydrate intake‐induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction

Durak, A. T., Akkuş, E., Canpolat, A. G., Tuncay, E., Çorapçıoğlu, D., & Turan, B. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13590 · Cited by 23 · see citing works

New antidiabetic therapy and HFpEF: light at the end of tunnel?

Tadić, M., Sala, C., Saeed, S., Grassi, G. M., Mancia, G., Rottbauer, W., & Cuspidi, C. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10106-9 · Cited by 23 · see citing works

Liraglutide ameliorates myocardial damage in experimental diabetic rats by inhibiting pyroptosis via Sirt1/AMPK signaling.

Zhang, Z., Wang, X., Yang, L., Yang, L., & Ma, H. (2021) · PubMed Central · doi:10.22038/ijbms.2021.56771.12677 · Cited by 22 · see citing works

The effect of glucagon‐like peptide‐1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta‐analysis

Zhang, Y., Yang, D., Jia, Q., Yan, J., & An, F. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15557 · Cited by 22 · see citing works

The effect of SGLT2 inhibitors and GLP1 receptor agonists on arterial stiffness: A meta-analysis of randomized controlled trials

Rizos, E. C., Tagkas, C. F., Asimakopoulos, A., Tsimihodimos, V., Anastasiou, G., Rizzo, M., Agouridis, A. P., & Ntzani, E. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108781 · Cited by 21 · see citing works

Effects of first‐line antidiabetic drugs on the improvement of arterial stiffness: A Bayesian network meta‐analysis

Wang, J., Wang, Y., Wang, Y., Li, Y., Zhang, J., Zhang, H., Fu, X., Guo, Z., Yang, Y., Kang, K., et al. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13405 · Cited by 20 · see citing works

Modern antidiabetic therapy by sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors against cardiovascular diseases

Steven, S., Kuntić, M., Münzel, T. F., & Daiber, A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100082 · Cited by 20 · see citing works

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes

Lo, C. W. H., Fei, Y., & Cheung, B. M. Y. (2021) · Cardiac failure review · doi:10.15420/cfr.2020.19 · Cited by 19 · see citing works

Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological Strategies

Muñoz‐Córdova, F., Hernández-Fuentes, C. P., López‐Crisosto, C., Troncoso, M. F., Calle, X., Guerrero‐Moncayo, A., Gabrielli, L., Chiong, M., Castro, P., & Lavandero, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.707336 · Cited by 19 · see citing works

Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss

Simeone, P., Tripaldi, R., Michelsen, A. E., Ueland, T., Liani, R., Ciotti, S., Birkeland, K. I., Gulseth, H. L., Castelnuovo, A. F. D., Cipollone, F., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01469-w · Cited by 19 · see citing works

Cardiac energy metabolism in diabetes: emerging therapeutic targets and clinical implications

Panwar, A., Malik, S. O., Adib, M., & Lopaschuk, G. D. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00615.2024 · Cited by 19 · see citing works

Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective Drugs

Lunder, M., Janić, M., & Šabović, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062796 · Cited by 20 · see citing works

Semaglutide concurrently improves vascular and liver indices in patients with type 2 diabetes and fatty liver disease

Korakas, E., Kountouri, A., Pavlidis, G., Oikonomou, E., Vrentzos, E., Michalopoulou, E., Tsigkou, V., Katogiannis, K., Pliouta, L., Balampanis, K., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae122 · Cited by 18 · see citing works

Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction

Yagi, K., Imamura, T., Tada, H., Chujo, D., Liu, J., Shima, Y., Ohbatake, A., Miyamoto, Y., Okazaki, S., Ito, N., et al. (2021) · Journal of Diabetes Research · doi:10.1155/2021/8838026 · Cited by 18 · see citing works

Glucagon-Like Peptide-1 Receptor Agonists in Adult Patients With Type 2 Diabetes: Review of Cardiovascular Outcome Trials

Varin, E. M., McLean, B. A., & Lovshin, J. A. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.08.011 · Cited by 17 · see citing works

Effects of Antidiabetic Drugs on Endothelial Function in Patients With Type 2 Diabetes Mellitus: A Bayesian Network Meta-Analysis

Wang, Y., Yao, M., Wang, J., Liu, H., Zhang, X., Zhao, L., Hu, X., Guan, H., & Lyu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.818537 · Cited by 18 · see citing works

Comparative effects of lipid lowering, hypoglycemic, antihypertensive and antiplatelet medications on carotid artery intima-media thickness progression: a network meta-analysis

Huang, R., Mills, K. E., Romero, J., Li, Y., Hu, Z., Cao, Y., Huang, H., Xu, Y., & Jiang, L. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0817-1 · Cited by 17 · see citing works

Molecular Insights into the Potential Cardiometabolic Effects of GLP-1 Receptor Analogs and DPP-4 Inhibitors

Król, M., Kupnicka, P., Żychowska, J., Kapczuk, P., Szućko-Kociuba, I., Prajwos, E., & Chlubek, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146777 · Cited by 17 · see citing works

The potential of glucagon-like peptide-1 receptor agonists in heart failure

Kreiner, F. F., Hovingh, G. K., & von Scholten, B. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.983961 · Cited by 16 · see citing works

Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study

Basile, P., Guaricci, A. I., Piazzolla, G., Volpe, S., Vozza, A., Benedetto, M., Carella, M. C., Santoro, D., Monitillo, F., Baggiano, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041586 · Cited by 16 · see citing works

β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease

Ikonomidis, I., Katogiannis, K., Kyriakou, E. S., Taichert, M., Katsimaglis, G., Tsoumani, M. E., Andreadou, I., Maratou, E., Lambadiari, V., Kousathana, F., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02060-4 · Cited by 16 · see citing works

Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis

Gerstein, H. C., Lee, S.-F., Paré, G., Bethel, M. A., Colhoun, H. M., Hoover, A., Lakshmanan, M. C., Lin, Y., Pirro, V., Qian, H.-R., et al. (2023) · Diabetes Care · doi:10.2337/dc22-2397 · Cited by 15 · see citing works

The association of diabetes mellitus with carotid atherosclerosis and arterial stiffness in the Corinthia study

Theofilis, P., Oikonomou, E. K., Lazaros, G. A., Vogiatzi, G., Anastasiou, Μ., Mystakidi, V. C., Goliopoulou, A., Christoforatou, E., Bourouki, E., Vavouranaki, G., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.12.013 · Cited by 15 · see citing works

Diabetes mellitus therapy in the light of oxidative stress and cardiovascular complications

Osman, A. A. M., Seres, A. B., & Ducza, E. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108941 · Cited by 14 · see citing works

Metabolic improvement with short‐term, glucagon‐like peptide‐1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial

Bojer, A. S., Sørensen, M. H., Bjerre, J., Gæde, P., Vejlstrup, N. G., & Madsen, P. L. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14480 · Cited by 14 · see citing works

Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes

Ikonomidis, I., Pavlidis, G., Pliouta, L., Katogiannis, K., Maratou, E., Thymis, J., Michalopoulou, E., Prentza, V., Katsanaki, E., Vlachomitros, D., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039129 · Cited by 13 · see citing works

Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures

Lundgren, J. R., Færch, K., Witte, D. R., Jonsson, A. E., Pedersen, O. B., Hansen, T. F., Lauritzen, T., Holst, J. J., Vistisen, D., Jørgensen, M. E., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0937-7 · Cited by 13 · see citing works

COVID-19, Endothelium and the Cardiometabolic Patient: A Possible Role for Capillary Leak Syndrome

Lambadiari, V., Korakas, E., Oikonomou, E. K., Bletsa, E., Kountouri, A., Goliopoulou, A., Ikonomidis, I., & Siasos, G. (2022) · Biomedicines · doi:10.3390/biomedicines10102379 · Cited by 12 · see citing works

Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes

Ferdinand, K. C., Dunn, J. P., Nicolay, C., Sam, F., Blue, E. K., & Wang, H. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01775-x · Cited by 13 · see citing works

Oxidative Stress and Antioxidant Therapy in Cardiovascular Diseases—Clinical Challenge

Pavlidis, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133784 · Cited by 12 · see citing works

Efficacy and Safety of Tirzepatide Compared with GLP-1 RAs in Patients with Type 2 Diabetes Treated with Basal Insulin: A Network Meta-analysis

Osumili, B., Sapin, H., Yang, Z., Ranta, K., Paik, J. S., & Blüher, M. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01728-5 · Cited by 12 · see citing works

Effect of GLP-1 RA and SGLT2I on Biomarkers of Oxidative Stress in T2DM: A Systematic Review and Meta-analysis

Wei, H., Ye, L., Li, M., Huang, S., & Mo, Z. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf075 · Cited by 12 · see citing works

Comparison of the effects of empagliflozin and glimepiride on endothelial function in patients with type 2 diabetes: A randomized controlled study

Tamura, H., Kondo, Y., Ito, K., Hasebe, M., Satoh, S., & Terauchi, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262831 · Cited by 11 · see citing works

HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction

Bosanac, J., Straus, L., Novaković, M., Košuta, D., Mijovski, M. B., Tasić, J., & Jug, B. (2022) · Disease Markers · doi:10.1155/2022/9539676 · Cited by 11 · see citing works

Changes in Left Ventricular Mechanics After Sleeve Gastrectomy

Santos, E. C. L., del Castillo, J. M., Parente, G. B., Pedrosa, R. P., Gadelha, P. S., Lópes, R. D., Kreimer, F., & Neto, F. R. M. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04216-5 · Cited by 11 · see citing works

Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain

Kim, Y., & Song, J. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa080 · Cited by 8 · see citing works

Transient receptor potential vanilloid type 1: cardioprotective effects in diabetic models

Bao, J., Gao, Z., Hu, Y., Ye, L., & Wang, L. (2023) · Channels · doi:10.1080/19336950.2023.2281743 · Cited by 9 · see citing works

Pharmacological countermeasures for long-duration space missions: addressing cardiovascular challenges and advancing space-adapted healthcare

Derobertmasure, A., Toh, L. S., Wotring, V. E., Williams, P. M., Morbidelli, L., Stingl, J., Vinken, M., Ramadan, R., Chhun, S., & Boutouyrie, P. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107063 · Cited by 8 · see citing works

Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction

Turan, B., Durak, A. T., Olğar, Y., & Tuncay, E. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04474-5 · Cited by 8 · see citing works

Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future

Chee, Y. J., & Dalan, R. (2024) · Biomedicines · doi:10.3390/biomedicines12071386 · Cited by 7 · see citing works

4324Effects of the glucagon like peptide-1 receptor agonist on arterial stiffness, LV myocardial deformation and oxidative stress in newly diagnosed type 2 diabetes after 6-month treatment

Ikonomidis, I., Pavlidis, G., Lambadiari, V., Kousathana, F., Triantafyllidi, H., Varoudi, M., Vlastos, D., Vlachos, S., Benas, D., Kalogeris, E., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy563.4324

P4455Improvement of arterial stiffness, LV myocardial deformation and endothelial glycocalyx is linked with reduced oxidative stress in diabetic type2 patients after optimization of antidiabetic medication

Ikonomidis, I., Pavlidis, G., Lambadiari, V., Kousathana, F., Triantafyllidi, H., Varoudi, M., Vlastos, D., Kostelli, G., Benas, D., Kalogeris, E., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx504.p4455

Effects of Liraglutide, Empagliflozin and Their Combination on Left Atrial Strain and Arterial Function

Katogiannis, K., Thymis, J., Kousathana, F., Pavlidis, G., Korakas, E., Kountouri, A., Balampanis, K., Prentza, V., Kostelli, G., Michalopoulou, H., et al. (2024) · Medicina · doi:10.3390/medicina60030395 · Cited by 21 · see citing works

Twelve-month treatment with glucagon-like peptide-1 receptor agonists or sodium-glucose co-transporter-2 inhibitors improves arterial function and myocardial deformation after ischemic stroke

Ikonomidis, I., Prentza, V., Pavlidis, G., Katogiannis, K., Thymis, J., Stamoulis, K., Kountouri, A., Pliouta, L., Korakas, E., Kostelli, G., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf784.3021

Glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors improve myocardial deformation and work index in type-2 diabetes after 12-month treatment

Ikonomidis, I., Pavlidis, G., Thymis, J., Birba, D., Kalogeris, A., Kousathana, F., Kountouri, A., Balampanis, K., Parissis, J., Andreadou, I., et al. (2020) · European Heart Journal · doi:10.1093/ehjci/ehaa946.0115